期刊
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
卷 18, 期 10, 页码 887-896出版社
ELSEVIER SCIENCE INC
DOI: 10.1097/JGP.0b013e3181e56cdc
关键词
Mortality; prediabetes; schizophrenia; veterans
资金
- Department of Veterans Affairs [IIR-05-326]
- VERDICT Research Center
- University of Texas Health Science Center at San Antonio
- Copeland as PI: VA HSRD
- Hogg Fndn/UT-Austin
- Copeland as co-I: VA HSRD
- VA VISN 17
- NIH
- Dept of Defense
- Parchman as PI: VA/HSRD
- NIDDK
- Parchman as co-I: VA HSRD
- Lawrence as PI: VA/HSRD
- Lawrence as co-I: VHA
- Zeber as PI: VA HSRD
- PhRMA Fndn
- UTHSCSA Training Pgm
- Zeber as co-I: VA HSRD
- Downs as PI: none Downs as co-I: VA/HSRD
- NINR
- Miller as PI: AstraZeneca
- Pfizer Organon
- UNC/NIMH
- Glaxo Smith Kline
- Pfizer
- Sanofi Aventis
- Janssen
- Miller as co-I: VA HSRD
- Research Foundation for Mental Hygiene New York
- CME, Inc. Orlando, FL
- France Foundation Atlanta, GA
- Organon (Advisory Board) Parsippany, NJ
- Dainippon Sumitomo (Advisory Board) Chicago
- Eli Lilly (Advisory Board) Scottsdale, AZ
- AstraZeneca (Advisory Board) Baltimore
- CME Outfitters Washington, DC
- Research Foundation for Mental Hygiene
- VA San Antonio, TX
- Comprehensive Neuroscience online survey
- NCME, Inc. French Camp, CA
- State of Maryland Baltimore
- NCME, Inc. Smithville, TX
- NCME, Inc. Reno, NV
- International Congress on Schizophrenia Research San Diego, CA
- VA HSRD
Objectives: Assess glycemic monitoring and follow-up. Design: Retrospective study using administrative data (October 2001-September 2005). Setting: Veterans Health Administration. Participants: A nationwide sample of 39,226 outpatients aged 50 years or older with schizophrenia. Patients had no diagnosis or medications for diabetes at baseline. Measurements: Hemoglobin A1c tests; blood glucose tests with same-day low-density lipoprotein to approximate fasting glucose. Glycemic tests were combined to indicate a) prediabetic dysglycemia (100-125 mg/dL proxy fasting glucose or 5.8%-6.4% hemoglobin A1c) and b) diabetic dysglycemia (>= 126 proxy fasting glucose or >= 6.5% A1c). Results: Approximately one-third of patients (32%; 12,587) had proxy fasting blood glucose or A1c tests in 2002; multiple tests were rare. The proportion tested increased to 40% by 2005. Test results suggested prediabetic dysglycemia for 5,345 tested patients (42% of those tested) and diabetic dysglycemia for 1,287 tested patients (10%) at baseline. In multivariate regression models, glycemic testing was associated with dyslipidemia, hypertension, and younger age. Dysglycemia was associated with hypertension, dyslipidemia, and older age. Follow-up treatment/diagnosis of diabetes occurred for 8% of patients (11% of those tested) and was associated with baseline dysglycemia, hypertension, and younger age. Mortality (15% during the 4-year study) was higher among untested and untreated patients. Conclusions: Dysglycemia was prevalent among older patients with schizophrenia, although monitoring and follow-up were uncommon. Follow-up treatment correlated with survival. Despite evident utility of testing, few at-risk patients with schizophrenia were adequately monitored, diagnosed, or treated for dysglycemia. (Am J Geriatr Psychiatry 2010; 18:887-896)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据